Introduction The advent of glucagon-like peptide-1 (GLP-1) receptor agonists marks a pivotal evolution in the management of type 2 diabetes and obesity. These therapies offer...
Introduction Obesity, a major public health challenge, has reached epidemic proportions globally. Defined by an abnormal or excessive fat accumulation that impairs health, it is...
Introduction Obesity has emerged as one of the most significant global public health challenges, with rising prevalence and far-reaching consequences on health systems and societal...